Skip to main content
CCSB logo

CCSB — Investor Relations & Filings

Ticker · 1762 ISIN · TW0001762003 TW Manufacturing
Filings indexed 1,608 across all filing types
Latest filing 2022-10-07 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1762

About CCSB

www.ccsb.com.tw

Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.

Recent filings

Filing Released Lang Actions
111年9月營業收入
Interim / Quarterly Report Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains financial data for a specific month and year (民國111年09月, which corresponds to September 2022) and compares it to the previous year. The document is short (774 characters) and appears to be a periodic financial summary rather than a full comprehensive report. It does not contain detailed financial statements or management discussion, nor is it an announcement of a meeting or voting results. Given the presence of actual financial data for a period shorter than a full fiscal year and the nature of the content, this fits the definition of an Interim / Quarterly Report (IR).
2022-10-07 Chinese
111年09月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of insiders, including directors, senior management, and their related parties. It shows the number of shares held, changes in holdings, and classifications of shares for various insiders. This type of document is typical of a Director's Dealing report, which discloses personal share transactions by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not an announcement of a report but a detailed disclosure of insider shareholdings and transactions. Therefore, the appropriate classification is Director's Dealing (DIRS).
2022-10-06 Chinese
111年09月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders, including directors, supervisors, and senior management, showing their current and pledged shares. It includes specific data on share counts, pledges, and related parties. There is no indication of financial results, earnings, or report publication. The content focuses on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives. The document length is about 3,000 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2022-10-06 Chinese
澄清111.09.17經濟日報B4版之報導。
Regulatory Filings Classification · 95% confidence The document is a short announcement (741 characters) from a company clarifying a media report. It states that the company is issuing a clarification regarding a news article and emphasizes that financial information should be based on official disclosures. There is no detailed financial data, no report attached or published, and no mention of a formal report filing. The content is a regulatory announcement clarifying information rather than a financial report or management discussion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2022-09-19 Chinese
111年8月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 中化生, reporting on the status of fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It contains no detailed financial statements, no management discussion, no voting results, no legal or regulatory announcements, and no mention of meetings or reports. The content is a regulatory disclosure of financial guarantees and loans, typical of a regulatory filing. The document length is short (602 characters), and it is a straightforward compliance disclosure without substantive financial data or analysis. Therefore, it fits best under Regulatory Filings (RNS).
2022-09-08 Chinese
111年8月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 中化生, presented in a tabular format with explanations about accounting standards and reporting practices. It contains actual financial data for a specific month and year (August 2022, 民國111年08月). The content is concise but includes substantive financial figures and explanations, indicating it is a periodic financial report rather than an announcement or a certification. Given the monthly and cumulative revenue data, it aligns with an Interim / Quarterly Report (IR) rather than a full Annual Report or Earnings Release, as it provides more detailed financial data than a simple earnings highlight. The document length is short but contains actual financial data, so it is not a report publication announcement or regulatory filing. Therefore, the best classification is Interim / Quarterly Report (IR).
2022-09-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.